Related Experiment Videos
Primary Breast Lymphoma-Population-Level Insights into an Infrequent but Increasingly Recognized Subtype of Lymphoma
Piers Blombery1, Henry M Prince1,2,3, John F Seymour1,2,4
1Peter MacCallum Cancer Centre, Melbourne, Australia.
Journal of the National Cancer Institute
|April 5, 2017
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Dynamic risk stratification using early CAR-T expansion in R/R LBCL treated with axicabtagene ciloleucel.
British journal of haematology·2026
Refined Continuous Risk Index for Accurately Predicting Outcomes of Patients With Chronic Lymphocytic Leukemia After Limited-Duration Therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Contemporary Management of Relapsed or Refractory Chronic Lymphocytic Leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
CRISPR in clinical oncology: translational advances from molecular diagnostics to therapeutics.
Nature reviews. Clinical oncology·2026
Perioperative ctDNA as a prognostic biomarker in endometrial cancer - the CODEC study.
Translational oncology·2026
Immunotherapy-Based Therapies in Pediatric Hodgkin Lymphoma: Potential to Narrow the Gap in Long-Term Survival.
Journal of the National Cancer Institute·2026
Epstein-Barr virus-attributable cancers among children and adolescents in Europe and North America: a meta-analysis.
Journal of the National Cancer Institute·2026
Two-to-one randomization is associated with increased control-arm patient withdrawal.
Journal of the National Cancer Institute·2026
Trends in U.S. breast cancer mortality by estrogen receptor status.
Journal of the National Cancer Institute·2026
Explaining educational differences in return to work after early breast cancer: a mediation analysis.
Journal of the National Cancer Institute·2026
Effectiveness of an exercise intervention on cognition in breast cancer survivors: a randomized controlled trial.
Journal of the National Cancer Institute·2026
Cancer immunoediting in the melanoma tumor microenvironment: from immune elimination to therapeutic resistance.
Frontiers in immunology·2026
Immune remodeling of tumor-draining lymph nodes: mechanistic determinants of checkpoint blockade responsiveness.
Frontiers in immunology·2026
Lymph node lymphatic PD-L1 regulates tumor-infiltrating T cells in immune checkpoint-sensitive melanoma.
Cancer research communications·2026
Breast cancer immunogenicity as a spectrum: evolving concepts and therapeutic implications.
The Journal of clinical investigation·2026